Ta. Maurer et al., THE USE OF METHOTREXATE FOR TREATMENT OF PSORIASIS IN PATIENTS WITH HIV-INFECTION, Journal of the American Academy of Dermatology, 31(2), 1994, pp. 372-375
The use of methotrexate (MTX) has been contraindicated for treatment o
f severe psoriasis in HIV infection on the basis of six previously rep
orted cases in which MTX appeared to potentiate opportunistic infectio
ns and accelerate HIV disease. We describe three HIV-infected patients
who were given MTX for severe psoriatic arthritis. In two patients op
portunistic infections did not develop. On the basis of survival data,
it is not clear that use of MTX adversely affected the natural course
of their HIV disease.